SSR 149415

Drug Profile

SSR 149415

Alternative Names: SR 149415; SSR149415

Latest Information Update: 12 Aug 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator sanofi-aventis
  • Class Antidepressants; Anxiolytics; Indoles; Pyrrolidines
  • Mechanism of Action Vasopressin 1b receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Generalised anxiety disorder; Major depressive disorder

Most Recent Events

  • 31 Jul 2008 Discontinued - Phase-I for Depression in France (PO)
  • 31 Jul 2008 Discontinued - Phase-II for Depression in Argentina (PO)
  • 31 Jul 2008 Discontinued - Phase-II for Depression in Bulgaria (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top